home / stock / otcff / otcff news

OTCFF News and Press, Ocumetics Technology

Stock Information
Company Name: Ocumetics Technology
Stock Symbol: OTCFF
Market: OTC
Website: ocumetics.com
Menu
Get OTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
OTCFF - Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones

(TheNewswire) Key Highlights $1.4 million of debenture principal converted to common shares of Ocumetics   Debt conversion represents 35% reduction in outstanding debenture principal   Calgary, Canada – TheNewswire - June 2, 2026 - Ocumetics T...
OTCFF - Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens

(TheNewswire) Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses   Production and testing of next-generation lenses now underway   New lens design incorporates insights from Group One First-in-Human...

OTCFF - Ocumetics Announces Offering of Units

(TheNewswire)     Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a private placement (the &...

OTCFF - Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life

(TheNewswire)   Key Highlights   Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements   Safety profile: Continues to meet expectations   Quality-of-life improvements: Anecdotal...
OTCFF - Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change

(TheNewswire) Key Highlights   No material change:  There is no material change in the business affairs of Ocumetics.   Attendance at ASCRS : Productive ASCRS meetings with major global ophthalmic leaders.   Clinical and development momentu...

OTCFF - Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting

(TheNewswire) Key Highlights   Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.  Ocumetics will leverage the conference to further engage with global strate...

OTCFF - Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design

(TheNewswire)   Key Highlights   Breakthrough Accommodating Interocular Lens Design: The enhanced lens design introduces several novel concepts that are expected to improve substantially upon the consistency, durability, and manufacturability of the lens.   ...
OTCFF - Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy

(TheNewswire)    Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, today announced ...

OTCFF - Ocumetics Announces Appointment of Raymond Marks to Board of Directors

(TheNewswire)   Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic technology, is pleased to announce ...

OTCFF - Ocumetics Announces Forbearance Agreement for $4 Million Secured Convertible Debentures and Provides LIFE Offering Update

(TheNewswire)   Calgary, Alberta – February 10, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce that the Corporation has entered into a...
Next 10